Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients
Status:
Recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability,
Pharmacokinetics and Preliminary Efficacy of BAT4706 Injection Combined With BAT1308
Injection in Patients With Advanced Solid Tumors.